Jujube in metabolic syndrome

The effect of jujube consumption on anthropometric indices, lipid parameters, blood pressure, glycemic status, and mood in military personnel with metabolic syndrome referred to Shahid Sadoughi Hospital in Isfahan

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180201038585N10

Enrollment

Registered

2021-04-11

Start date

2021-04-09

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome. Metabolic syndrome

Interventions

Intervention 1: Intervention group: Patients in the intervention group will receive 30 g packets of jujube powder at the beginning of the study. Patients in the intervention group will be asked to con

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Military personnel with metabolic syndrome Age 30-50 years Willing to participate in the study

Exclusion criteria

Exclusion criteria: Follow special diets Other diseases such as kidney, liver, thyroid and parathyroid, lung, cancer, and heart disease

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Mercury sphygmomanometer.;Weight. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Scale.;Body mass index. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Equation, Weight(kg)/[height(m)]2.;Lipid profile. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Through intravenous blood samples and commercial kits.;Fasting blood glucose. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Through intravenous blood samples and commercial kits.;Waist circumference. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Tape.	—

Measure

Time frame

Blood pressure. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Mercury sphygmomanometer.;Weight. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Scale.;Body mass index. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Equation, Weight(kg)/[height(m)]2.;Lipid profile. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Through intravenous blood samples and commercial kits.;Fasting blood glucose. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Through intravenous blood samples and commercial kits.;Waist circumference. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: Tape.

—

Secondary

Measure	Time frame
Depression score. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: DASS-21 questionnaire.;Stress score. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: DASS-21 questionnaire.;Anxiety score. Timepoint: At the beginning and after 8 weeks of study. Method of measurement: DASS-21 questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKarim Parastouei

Bagheiat-allah University of Medical Sciences

parastouei@bmsu.ac.ir+98 21 8248 3516

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026